Fund shareholders of PHIO PHARMACEUTICALS CORP
ISIN US71880W5013 · United States · LEI 549300KOGMLSPLDVHR52
- Fund shareholders
- 7
- Of which ETFs
- 0 7 other funds
- Value held
- 280.7K $
- Share of capital
- 2.3 % of 11.6M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 94,262 | 96.6K $ | 0.00 % | 0.81 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 80,599 | 89.5K $ | 0.00 % | 0.69 % | as of May 31, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 50,000 | 51.3K $ | 0.01 % | 0.43 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 14,664 | 16.3K $ | 0.13 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 13,285 | 14.7K $ | 0.11 % | as of May 31, 2026 ↗ | |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 12,000 | 12.3K $ | 0.01 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 4 | 4.1 $ | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.01 % | as of Jun 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 0.01 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 7 | +1 | 264,814 | +26.4 % |
| 2026Q2 | 6 | +1 | 209,587 | +76.9 % |
| 2026Q1 | 5 | -2 | 118,453 | -19.1 % |
| 2025Q4 | 7 | +1 | 146,473 | +10.5 % |
| 2025Q3 | 6 | +1 | 132,595 | +128.3 % |
| 2025Q2 | 5 | +1 | 58,086 | +614.3 % |
| 2025Q1 | 4 | -1 | 8,132 | -14.9 % |
| 2024Q4 | 5 | 9,553 |
Institutional managers
22 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 147,254 | 179.6K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 119,189 | 145.4K $ | as of Mar 31, 2026 |
| Cetera Investment Advisers | 45,000 | 54.9K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 34,732 | 42 $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 32,495 | 39.6K $ | as of Mar 31, 2026 |
| Scientech Research LLC | 30,032 | 36.6K $ | as of Mar 31, 2026 |
| UBS Group AG | 26,987 | 32.9K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 24,868 | 30.3K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 23,758 | 29K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 19,864 | 24 $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 15,224 | 18.6K $ | as of Mar 31, 2026 |
| CAPTRUST FINANCIAL ADVISORS | 10,000 | 12.2K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 7,620 | 9.3K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 6,000 | 7.3K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 2,000 | 2.4K $ | as of Mar 31, 2026 |
| Spire Wealth Management | 2,000 | 2.4K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 1,224 | 1.5K $ | as of Mar 31, 2026 |
| NBC SECURITIES, INC. | 1,074 | 1.3K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1,025 | 1.3K $ | as of Mar 31, 2026 |
| ASSETMARK, INC | 110 | 134 $ | as of Mar 31, 2026 |
| Activest Wealth Management | 9 | 11 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 3 | 4 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of PHIO PHARMACEUTICALS CORP". https://titelia.com/en/stocks/phio-pharmaceuticals-corp-US71880W5013